Skip to main content
SpringerLink
Log in

Unerlässliche und kritische Vakzinen

Impfen bei Immunschwäche: Das ist zu beachten

Vaccination of the immunocompromised patient

  • FORTBILDUNG . ÜBERSICHT
  • Published:
MMW - Fortschritte der Medizin Aims and scope

Impfen ist insbesondere bei immundefizienten Patienten eine wichtige Schutzmaßnahme. Welche Impfungen sind unproblematisch, welche müssen gut abgewogen werden? Welches Vorgehen ist vor geplanter Immunsuppression empfehlenswert?

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Niehues T, Bogdan C, Hecht J, Mertens T, Wiese-Posselt M, Zepp F. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017;60(6):674–84.

    Article  Google Scholar 

  2. Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014;58(3):e44–100.

    Article  Google Scholar 

  3. Buhler S, Eperon G, Ribi C, Kyburz D, van Gompel F, Visser LG, et al. Vaccination recommendations for adult patients with autoimmune inflammatory rheumatic diseases. Swiss Med Wkly. 2015;145:w14159.

    PubMed  Google Scholar 

  4. STIKO. Hinweise zu Impfungen für Patienten mit Immundefizienz.. Epidemiologisches Bulletin. 2005.

  5. Valour F, Cotte L, Voirin N, Godinot M, Ader F, Ferry T, et al. Vaccination coverage against hepatitis A and B viruses, Streptococcus pneumoniae, seasonal flu, and A(H1N1)2009 pandemic influenza in HIV-infected patients. Vaccine. 2014;32(35):4558–64.

    Article  Google Scholar 

  6. Grabmeier-Pfistershammer K, Herkner H, Touzeau-Roemer V, Rieger A, Burgmann H, Poeppl W. Low tetanus, diphtheria and acellular pertussis (Tdap) vaccination coverage among HIV infected individuals in Austria. Vaccine. 2015;33(32):3929–32.

    Article  CAS  Google Scholar 

  7. Loubet P, Kerneis S, Groh M, Loulergue P, Blanche P, Verger P, et al. Attitude, knowledge and factors associated with influenza and pneumococcal vaccine uptake in a large cohort of patients with secondary immune deficiency. Vaccine. 2015;33(31):3703–8.

    Article  Google Scholar 

  8. Durham MD, Buchacz K, Armon C, Patel P, Wood K, Brooks JT, et al. Rates and correlates of influenza vaccination among HIV-infected adults in the HIV Outpatient Study (HOPS), USA, 1999-2008. Prev Med. 2011;53(1-2):89–94.

    Article  Google Scholar 

  9. Institut RK. Ist es ratsam, Patienten mit Multipler Sklerose (MS) oder anderen demyelinisierenden neurologischen Erkrankungen zu impfen? 2012 [Available from: http://www.rki.de/SharedDocs/FAQ/Impfen/AllgFr_Grunderkrankungen/FAQ04.html.

  10. Edwards S, Zvartau M, Clarke H, Irving W, Blumhardt LD. Clinical relapses and disease activity on magnetic resonance imaging associated with viral upper respiratory tract infections in multiple sclerosis. J Neurol Neurosurg Psychiatry. 1998;64(6):736–41.

    Article  CAS  Google Scholar 

  11. Panitch HS. Influence of infection on exacerbations of multiple sclerosis. Ann Neurol. 1994;36 Suppl:S25–8.

    Article  Google Scholar 

  12. Sibley WA, Bamford CR, Clark K. Clinical viral infections and multiple sclerosis. Lancet. 1985;1(8441):1313–5.

    Article  CAS  Google Scholar 

  13. Robert-Koch-Institut. epidemiologisches Bulletin. Berlin: Robert Koch Institut; 2004. p. 261-8.

  14. Koch-Institut“ SIaR. Empfehlungen der Ständigen Impfkommission (STIKO) beim Robert Koch-Institut — 2018/2019. Epidemiologisches Bulletin. 2018(34):335-78.

  15. Wiedermann U, Sitte HH, Burgmann H, Eser A, Falb P, Holzmann H, et al. [Guidelines for vaccination of immunocompromised individuals]. Wien Klin Wochenschr. 2016;128 Suppl 4:337–76.

    Article  CAS  Google Scholar 

  16. Centers for Disease C, Prevention. Measles pneumonitis following measles-mumps-rubella vaccination of a patient with HIV infection, 1993. MMWR Morb Mortal Wkly Rep. 1996;45(28):603–6.

    Google Scholar 

  17. Gershon AA, Steinberg SP. Persistence of immunity to varicella in children with leukemia immunized with live attenuated varicella vaccine. N Engl J Med. 1989;320(14):892–7.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Immunologie und Rheumatologie, Medizinische Hochschule Hannover, Hannover, Deutschland

    Alexandra Jablonka

  2. Institut für Infektionsmedizin und Krankenhaushygiene, Univ.-Klinikum Jena, Am Klinikum 1, D-07747, Jena, Deutschland

    Alexandra Jablonka, Steve Rößler,  Mathias W. Pletz &  Benjamin T. Schleenvoigt

Authors
  1. Alexandra Jablonka
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Steve Rößler
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mathias W. Pletz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Benjamin T. Schleenvoigt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Benjamin T. Schleenvoigt.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jablonka, A., Rößler, S., Pletz, M.W. et al. Impfen bei Immunschwäche: Das ist zu beachten. MMW - Fortschritte der Medizin 161, 56–60 (2019). https://doi.org/10.1007/s15006-019-0715-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-019-0715-1

Keywords

Search

Navigation